• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Newsmakers: Darren Shirley

    Are You Prepared for the 2023 DSCSA Deadline?

    Rethinking the Changing Role of the CRO

    23rd Annual Salary Survey

    Pharma 4.0 and the Modernizing Power of Digital Technology Transfer
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Pierre Fabre and Lonza Enter Manufacturing Agreement

    MasterControl and Elemental Machines Form Biomanufacturing Partnership

    Qosina Strengthens Aseptic Capabilities

    Charles River and Ziphius Vaccines to Manufacture saRNA-based Vaccine

    MilliporeSigma Opens $65M CDMO Facility for Cancer Therapies
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Pierre Fabre and Lonza Enter Manufacturing Agreement

    Qosina Strengthens Aseptic Capabilities

    MilliporeSigma Opens $65M CDMO Facility for Cancer Therapies

    Antheia Receives $40 million in Venture Debt Financing

    BioNTech Breaks Ground on First mRNA Vax Mfg. Facility in Africa
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Tubular Glass Primary Packaging for Pharmaceutical, Biotech and Diagnostic Containment

    How to Improve the Cold Chain System in Remote Locations

    Sentry Biopharma Services: Protecting Pharmaceutical Integrity

    Yourway to Build New Flagship European Depot

    Newsmakers: Darren Shirley
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    MasterControl and Elemental Machines Form Biomanufacturing Partnership

    Charles River and Ziphius Vaccines to Manufacture saRNA-based Vaccine

    Cullinan Oncology, Taiho to Develop & Commercialize CLN-081/TAS6417 in the U.S.

    BioNTech Breaks Ground on First mRNA Vax Mfg. Facility in Africa

    Tubular Glass Primary Packaging for Pharmaceutical, Biotech and Diagnostic Containment
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Should Remote Pharma GMP Audits End After COVID?

    Why is Big Pharma Increasingly Adopting 505(b)(2)?

    Sentry Biopharma Services: Protecting Pharmaceutical Integrity

    Selkirk Pharma Appoints New Head of Quality

    Be Safer by Doing Less: The Future of Zero Touch AE Case Processing
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Quotient Sciences

    Kyongbo Pharmaceutical

    CMC Pharmaceuticals

    IDT Biologika

    Biosynth Carbosynth
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Quotient Sciences

    Kyongbo Pharmaceutical

    CMC Pharmaceuticals

    IDT Biologika

    Biosynth Carbosynth
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    5 Reasons Paper Has No Place in Contract Manufacturing

    Digital solutions create more efficient manufacturing processes and eliminate delays.

    5 Reasons Paper Has No Place in Contract Manufacturing
    Related CONTENT
    • Legacy Pharma Solutions
    • Taros Chemicals GmbH & Co. KG
    • PCI Pharma Services
    • Sekisui
    • pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray
    Dave Edwards, Chief Revenue Officer, MasterControl03.01.21
    This year holds the promise of everyone receiving a vaccine for COVID-19. Contract pharmaceutical manufacturers are at the heart of these efforts, and skyrocketing demand requires the industry to move even faster than before. There couldn’t be a more important time to evaluate manufacturing processes and eliminate anything causing unnecessary delays, and there are five key reasons why the first thing to go should be paper on the shop floor.

    1. During a labor shortage, pushing paper costs time nobody can afford
    An urgent need for COVID-19 vaccines and treatments has created a considerable labor shortage within the contract manufacturing industry.

    The Wall Street Journal recently reported an estimated six billion doses of COVID-19 vaccines will be produced in 2021. The major pharmaceutical companies with a vaccine candidate are relying on contract manufacturers to help with production. The strain on resources is apparent as the world’s 10 largest companies that won COVID-19 outsourcing work have more than 5,000 job openings, and it’s a struggle to fill everything from specialized roles to overnight shifts.

    Under these circumstances, it’s imperative that shop floor workers make valuable use of their time, and paper-based manufacturing processes are slowing them down.

    Case in point, I remember visiting the shop floor of a medical device company in the UK. My first impression was positive because they appeared to have an efficient process in place for their paper batch records. Later, when we crunched some numbers, they revealed a very different picture.

    We estimated the operators spent about three hours per week completing paperwork, and that didn’t include review time. Three hours sounds fairly benign, but with more than 450 employees, the hours they spent pushing paper each week is the equivalent of 30 full-time employees. Consider how much can be accomplished by 30 employees.

    When the industry is scrambling to find workers to produce a life-saving vaccine needed around the globe, it doesn’t make sense to use paper-based processes. Eliminate them and adopt a digital solution to boost efficiency at a time when it’s needed most.

    2. Unlike paper, a digital solution provides actionable insights
    To elaborate on my first point, paper-based processes are incredibly time consuming and digitization streamlines these efforts. For example, the life sciences industry accumulates a lot of information, and managers generally try and use it to help guide business decisions. When this information is spread across multiple documents that are saved in different locations, gathering the right data becomes a logistical nightmare.

    Research conducted by Vanson Bourne showed that on average:
    • Eight hours per week are lost searching for, acquiring, entering or moving data around;
    • IT decision-makers spend five hours connecting, integrating or maintaining data. They spend that same amount of time on new, more strategic initiatives; and
    • Business users in the U.S. spend more than 35 minutes per day moving data from one system to another.

    A digital system is connected and stores data in one location. The information you collect, like everything entered into an electronic batch record, is data you can analyze to gain insights into business performance. This makes it possible for executives and managers to make data-driven decisions that are proactive rather than reactive—and even predictive.

    Ultimately, having the right data helps you to accomplish more with less. Time is at a premium right now, which makes digitization an ideal way to maximize productivity and keep pace with the industry.

    3. It’s essential to scale quickly, and that’s impossible to do with paper
    Paper simply can’t scale at the same rate as demand for contract pharmaceutical manufacturing, which means companies using paper-based processes are being slowed down in an industry that is only picking up speed.

    Manufacturing COVID-19 vaccines is an urgent priority today and the needs that existed prior to the pandemic still require attention. Contract manufacturers are scaling up for the high-volume manufacturing necessary for vaccine production, but they need to remain flexible to compete in emerging markets. In 2019, a quarter of new drugs approved by the FDA were personalized medicines, presenting lucrative opportunities within contract pharmaceutical manufacturing. Companies that can scale quickly are positioned to benefit the most.

    “Products for small patient groups create a different set of manufacturing demands and business models, with shorter runs and facilities and operations that must go patient to vein in short order. CDMOs are learning to accommodate these new demands and they create opportunities for nimble, well-run manufacturers,” explained Gil Roth, President and Founder of the Pharma & Biopharma Outsourcing Association.

    This type of scalability is only possible through digitization, which makes digitization key to taking advantage of the opportunities created by the surge in demand for contract manufacturers.

    4. Companies relying on paper risk falling behind, but they can get ahead with new technology
    In a world that is increasingly dependent on technology, businesses that don’t adapt risk becoming obsolete.

    A classic example of this is Blockbuster. The chain of video rental stores was enormously popular, but then Netflix emerged with a completely new business model, and while they explored ways to make the video rental experience entirely digital, Blockbuster held tightly to their brick and mortar stores. In 2008 their CEO declared, “Neither RedBox nor Netflix are even on the radar in terms of competition,” and just two years later, Blockbuster filed for bankruptcy. Meanwhile, Netflix continues to challenge other entertainment giants, and their value recently surpassed that of Disney.

    Blockbuster’s inability to adapt to new technology spelled the end for a business that once dominated an industry, and an early toe hold in the demand for digital services is what skyrocketed Netflix to success.

    Today, digitization is an opportunity for contract pharmaceutical manufacturers to streamline business operations and thrive in a constantly changing industry. Those who adopt new technology will quickly surpass companies who insist that paper worked back then and still works today.

    A recent article published by McKinsey & Company noted the many ways digitization positions a company to remain ahead of their competition. They reported, “Through digital transformation, manufacturers have seen significant improvements including less machine downtime, an increase in employee productivity, increased throughput, and decreases in the cost of quality.”

    In time, paper processes will be antiquated and organizations that were slow to adopt new technology will struggle to keep up with their competitors who digitized today.

    5. It’s essential to get to market quickly, and paper can slow you down
    When it comes to getting COVID-19 vaccines ready, speed is imperative. In a paper-based manufacturing environment, human errors made throughout the production cycle can accumulate and result in delays that take days or even weeks to fix.

    Someone on the shop floor might write down the wrong number on a batch record. Later, that batch record is reviewed as part of the post-production process, which means someone has to track down the right information and correct the batch record. Throughout the process, finished product sits waiting to ship. And unfortunately, this happens pretty often.

    A company I worked with had a 20% first pass approval rate, which means 80% of the time, additional follow-up was needed before a batch record was complete and ready to ship. That’s not ideal, and the majority of these common data input errors are avoidable.

    Digitization makes it possible to ensure data is entered right the first time, which shortens documentation review cycles. In one instance, a contract pharmaceutical manufacturer of nutraceuticals had post-production reviews that were taking as long as two weeks. The company adopted a digital solution and decreased data entry errors by over 90%. Having the right technology shortened review time to just three days.

    As another example, a contract pharmaceutical packaging company with more than 200 batch records spent up to three hours reviewing each one. The company did a trial run with a digital solution, and the amount of time spent on quality reviews was reduced to 15-20 minutes per batch record. To put it another way, if you add up the person-hours, the company went from spending the equivalent of two months on batch record reviews to completing a review of the same information in less than two weeks.

    Doing away with paper-based processes and digitizing saves time by making sure most mistakes are corrected in real-time. Then it’s possible to conduct a review by exception, and it’s only necessary to look at exceptions that occurred during the production run. The end result is eliminating avoidable delays, being more productive with the hours available in a workday, and getting quality products to market faster.

    In conclusion, paper hinders almost every aspect of manufacturing processes and needs to be eliminated from the shop floor. Digitization allows workers to spend time on value-added activities and makes it possible to collect data to make informed business decisions that are proactive and ultimately provide a competitive edge. The right manufacturing solution helps a company maintain that lead by making it possible to scale rapidly and adapt to ever-changing market conditions. These advantages all result in maintaining high quality standards while manufacturing batches without any of the delays caused by paper. 

    References
    1. “Covid-19 Vaccines Are in High Demand, but Thousands More Workers Are Needed to Make Them,” Elizabeth Koh, Wall Street Journal, January 4, 2021.
    2. “The High Cost of Disconnected Data,” SnapLogic, 2017
    3. "The personalized medicine Report," Personalized Medicine Coalition, 2020.
    4. “Keynote: The Future of Drug Manufacturing,” Dong Soo Kang and Gil Roth, CPhI festival of pharma®, October 5-16, 2020.
    5. “The Rise and Fall of Blockbuster and How It’s Surviving With Just One Store Left,” Andy Ash, Business Insider, August 12, 2020.
    6. “13 Quotes From Bosses Who Mocked Technology and Got It (Very) Wrong,” Grahm Rapier, Inc.
    7. “Why Netflix Is Worth More Than Disney,” Dana Blankenhorn, InvestorPlace, November 6, 2020
    8. “Preparing for the next normal via digital manufacturing’s scaling potential,” Enno de Boer, Søren Fritzen, Rehana Khanam, and Frédéric Lefort, McKinsey & Company, Apr. 10, 2020.


    Dave Edwards brings more than two decades of sales, manufacturing, customer service, and general business management experience to MasterControl, a leading global provider of software solutions that enable life science and other regulated companies to deliver life-changing products to more people sooner. Edwards most recently served as the chief operating officer at 3form, a leading manufacturer of translucent building materials in the architecture and design industry. Prior to 3form, he worked at Danaher Corp., a Fortune 500 manufacturing conglomerate, and at TenFold Corp., an enterprise software company. Edwards holds an MBA from Harvard Business School and a bachelor’s degree in economics from the University of Utah.
    Related Searches
    • Information Technology
    Suggested For You
    Legacy Pharma Solutions Legacy Pharma Solutions
    Taros Chemicals GmbH & Co. KG Taros Chemicals GmbH & Co. KG
    PCI Pharma Services PCI Pharma Services
    Sekisui Sekisui
    pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray
    Immunic Inc. Signs In-License Agreement with University Medical Center Goettingen, Germany Immunic Inc. Signs In-License Agreement with University Medical Center Goettingen, Germany
    Naobios to Manufacture FluGen’s M2SR Flu Vax Candidate  Naobios to Manufacture FluGen’s M2SR Flu Vax Candidate
    Clean Cells Expands Bioproduction Capabilities Clean Cells Expands Bioproduction Capabilities
    CEO Spotlight: Gaston Salinas, Botanical Solution Inc. CEO Spotlight: Gaston Salinas, Botanical Solution Inc.
    Lakes BioScience Signs Agreement with Cytvia Lakes BioScience Signs Agreement with Cytvia
    Boyds Opens US Office in PA Boyds Opens US Office in PA
    Boehringer Ingelheim, Twist Bioscience Enter Antibody Discovery Collaboration Boehringer Ingelheim, Twist Bioscience Enter Antibody Discovery Collaboration
    Repligen and Navigo Launch Antibody Technology Platform Repligen and Navigo Launch Antibody Technology Platform
    GeneQuine, Exothera Enter Gene Therapy Partnership GeneQuine, Exothera Enter Gene Therapy Partnership
    GeneQuine Contracts Exothera to Support the Development of Its Osteoarthritis Gene Therapy GeneQuine Contracts Exothera to Support the Development of Its Osteoarthritis Gene Therapy

    Related Buyers Guide Companies

    • Legacy Pharma Solutions

      Legacy Pharma Solutions

      ...
      Nathan Bender, Director, Sales & Marketing 12.07.21

    • Taros Chemicals GmbH & Co. KG

      ...
      Dimitrios Tzalis, Manager Executive Projects 12.07.21

    • Drug Development
      PCI Pharma Services

      PCI Pharma Services

      ...
      Jessica Kloster, Marketing Manager 10.20.21


    • Sekisui

      ...
      Jim Alferman, Associate Director, Business Development 10.13.21

    • Breaking News | Clinical Trials
      pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray

      pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray

      According to the study, the novel prophylactic nasal spray prevented infection from SARS-CoV-2, the virus that causes COVID-19.
      09.22.21

    Loading, Please Wait..
    Trending
    • Machine Learning-based Predictive Modeling: Notable Uses In Clinical Trials
    • Pierre Fabre And Lonza Enter Manufacturing Agreement
    • MilliporeSigma Opens $65M CDMO Facility For Cancer Therapies
    • 17th Annual Contracting & Outsourcing Conference Photos
    • Curia And Replicate Bioscience Enter SrRNA Collaboration
    Breaking News
    • Qosina Strengthens Aseptic Capabilities
    • Pierre Fabre and Lonza Enter Manufacturing Agreement
    • Charles River and Ziphius Vaccines to Manufacture saRNA-based Vaccine
    • MasterControl and Elemental Machines Form Biomanufacturing Partnership
    • MilliporeSigma Opens $65M CDMO Facility for Cancer Therapies
    View Breaking News >
    CURRENT ISSUE

    June 2022

    • Newsmakers: Darren Shirley
    • Are You Prepared for the 2023 DSCSA Deadline?
    • Rethinking the Changing Role of the CRO
    • 23rd Annual Salary Survey
    • Pharma 4.0 and the Modernizing Power of Digital Technology Transfer
    • CEO Spotlight: David Chang
    • Changes are on the Horizon for Single-use Systems in Pharmaceutical Manufacturing
    • CRO Industry Market Report
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Florida Food Products Acquires Javo
    Roquette Launches Nutralys Rice Protein
    New IADSA Chair Lauds Explorations of Supplementation in Healthcare Policy
    Coatings World

    Latest Breaking News From Coatings World

    The Southern Society for Coatings Technology's 84th Annual Technical Conference A Success
    PPG to Showcase Specialty Automotive, Aerospace Adhesives, Sealants at Adhesives & Bonding Expo
    PPG’s New Paint for a New Start Initiative to Transform 25-plus Schools Worldwide
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most Read Stories This Week—June 25
    Magnetic Insight Announces $17 Million in Series B Funding
    BreatheSuite Adds Brad Fluegel to its Board
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pierre Fabre and Lonza Enter Manufacturing Agreement
    MasterControl and Elemental Machines Form Biomanufacturing Partnership
    Qosina Strengthens Aseptic Capabilities
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Benefit Exec Joins Madison Reed's Board
    Peroni & Ellis Brooklyn Launch Fragrance Collection Inspired by Italian Spritz Cocktails
    Rhode Is Trending for June, Trendalytics Says
    Happi

    Latest Breaking News From Happi

    Spate’s Nose for the Latest Beauty Trends Says The Skunk Stripe, Collagen Serum and Waterproof Eyeshadow are Top of Mind for Consumers this Summer
    A Suitor Emerges for Revlon, SK Capital’s New Dealmaker & P&G’s Indoor Air Quality Efforts
    Wonder Curl Wins GlossWire's GlossPitch Competition
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: INX’s VC Fund, Screen Industry and Ball Top This Week’s News
    British Coatings Federation Posts Online History
    Orion Announces Price Increases, Reduced Payment Terms
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    PCMC teams with IGT, Fujifilm makes big announcement and more
    Loftware recognized as 'AIDC Company of the Year'
    Schreiner MediPharm highlights sustainability of Needle-Trap technology
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: SWM and Neenah Introduce Mativ Inc., Avgol honored for Biotransformation Technology & More
    Tranzonic Names VP of Supply Chain
    Ontex Climate Action Targets Approved by Science-Based Targets Initiative
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—June 25
    3Spine Inc. Receives IDE Approval for U.S. Pivotal Clinical Trial
    Volume-Based Procurement to Reduce Chinese Orthopedic Market Value
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: eMagin, Applied Materials, and Schott Top This Week’s Stories
    NREL Names Jennifer Logan to Leadership Team as CFO
    National Grid Renewables Orders 2 GW of First Solar Modules

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login